| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activation of TNF-α-AID axis and co-inhibitory signals in coordination with Th1-type immunity in a mouse model recapitulating hepatitis B
|
Matsumoto, Tomonori
|
|
2017
|
139 |
C |
p. 138-145
8 p.
|
artikel
|
| 2 |
Activity of andrographolide against dengue virus
|
Panraksa, Patcharee
|
|
2017
|
139 |
C |
p. 69-78
10 p.
|
artikel
|
| 3 |
A profiling study of a newly developed HCVcc strain PR63cc's sensitivity to direct-acting antivirals
|
Tao, Wanyin
|
|
2017
|
139 |
C |
p. 18-24
7 p.
|
artikel
|
| 4 |
Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox
|
Crump, Ryan
|
|
2017
|
139 |
C |
p. 112-116
5 p.
|
artikel
|
| 5 |
Discovery of host-targeted covalent inhibitors of dengue virus
|
de Wispelaere, Mélissanne
|
|
2017
|
139 |
C |
p. 171-179
9 p.
|
artikel
|
| 6 |
Eukaryotic translational initiation factor 4AII reduces the replication of infectious bursal disease virus by inhibiting VP1 polymerase activity
|
Gao, Li
|
|
2017
|
139 |
C |
p. 102-111
10 p.
|
artikel
|
| 7 |
Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus
|
Li, Kai
|
|
2017
|
139 |
C |
p. 153-160
8 p.
|
artikel
|
| 8 |
Extended substrate specificity and first potent irreversible inhibitor/activity-based probe design for Zika virus NS2B-NS3 protease
|
Rut, Wioletta
|
|
2017
|
139 |
C |
p. 88-94
7 p.
|
artikel
|
| 9 |
Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus
|
Lee, Hyun
|
|
2017
|
139 |
C |
p. 49-58
10 p.
|
artikel
|
| 10 |
Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivation
|
Vemula, Sai Vikram
|
|
2017
|
139 |
C |
p. 161-170
10 p.
|
artikel
|
| 11 |
Inside Back Cover: Notes to Authors
|
|
|
2017
|
139 |
C |
p. IBC-
1 p.
|
artikel
|
| 12 |
Meeting report: Third Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS)
|
Le Grice, Stuart F.J.
|
|
2017
|
139 |
C |
p. 13-17
5 p.
|
artikel
|
| 13 |
Modelling viral infections using zebrafish: Innate immune response and antiviral research
|
Varela, Mónica
|
|
2017
|
139 |
C |
p. 59-68
10 p.
|
artikel
|
| 14 |
Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism
|
Kuivanen, Suvi
|
|
2017
|
139 |
C |
p. 117-128
12 p.
|
artikel
|
| 15 |
Porcine parvovirus capsid protein expressed in Escherichia coli self-assembles into virus-like particles with high immunogenicity in mice and guinea pigs
|
Ji, Pengchao
|
|
2017
|
139 |
C |
p. 146-152
7 p.
|
artikel
|
| 16 |
Prelim II: Editorial Board
|
|
|
2017
|
139 |
C |
p. ii-
1 p.
|
artikel
|
| 17 |
Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor
|
Yajima, Misako
|
|
2017
|
139 |
C |
p. 95-101
7 p.
|
artikel
|
| 18 |
Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model
|
Kumaki, Yohichi
|
|
2017
|
139 |
C |
p. 1-12
12 p.
|
artikel
|
| 19 |
Protein kinases C as potential host targets for the inhibition of chikungunya virus replication
|
Abdelnabi, Rana
|
|
2017
|
139 |
C |
p. 79-87
9 p.
|
artikel
|
| 20 |
Structure-activity relationship studies on a Trp dendrimer with dual activities against HIV and enterovirus A71. Modifications on the amino acid
|
Martínez-Gualda, Belén
|
|
2017
|
139 |
C |
p. 32-40
9 p.
|
artikel
|
| 21 |
Tenofovir alafenamide demonstrates broad cross-genotype activity against wild-type HBV clinical isolates and maintains susceptibility to drug-resistant HBV isolates in vitro
|
Liu, Yang
|
|
2017
|
139 |
C |
p. 25-31
7 p.
|
artikel
|
| 22 |
Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation
|
Kobayashi, Masanori
|
|
2017
|
139 |
C |
p. 41-48
8 p.
|
artikel
|
| 23 |
Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy
|
Khera, Tanvi
|
|
2017
|
139 |
C |
p. 129-137
9 p.
|
artikel
|
Tijdschrift beschrijving